The 18th Japan-Korea H. pylori Joint Symposium

Time Table

Program

Opening Remarks

Saturday, June 25th, 2022 15:30-15:35 Room 2(1F naruo)

  • President of The Japanese Society for Helicobacter Research:
  • Kazunari Murakami
  • (Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan)

Symposium 1

Saturday, June 25th, 2022 15:35-16:05 Room 2(1F naruo)

New diagnostic tests for H. pylori infection in Japan and Korea

  • Chair: Soo-Heon Park
  • (The Catholic University of Korea, Korea)
  • Tadashi Shimoyama
  • (Aomori General Health Examination Center, Japan)
  • JS1-1 New diagnostic test for H. pylori in Japan and Korea (Sweeping rapid urease test vs conventional RUT)
  • Kee Myung Lee
  • (Ajou University of Korea, Korea)
  • JS1-2 Clinical evaluation of H. pylori molecular diagnosis POCT kit based on Qprobe using gastric juice
  • Momoko Tsuda
  • (Department of Gastroenterology, National Hospital Organization Hakodate National Hospital, Japan)

Symposium 2

Saturday, June 25th, 2022 16:05-16:35 Room 2(1F naruo)

Current problems in the eradication of H. pylori in Japan and Korea

  • Chair: Jong-Jae Park
  • (Korea University, Korea)
  • Mitsushige Sugimoto
  • (Department of Gastroenterological Endoscopy, Tokyo Medical University, Japan)
  • JS2-1 Current problems in the eradication of H. pylori in Korea
  • Byung-Wook Kim
  • (Department of Internal Medicine, Incheon St. Mary’s Hospital, The Catholic University of Korea, Korea)
  • JS2-2 Surveillance of Helicobacter pylori antibiotic susceptibility in Japan
  • Tadayoshi Okimoto
  • (Japanese Society for Helicobacter Research drug resistant surveillance Committee, Japan)

Symposium 3

Saturday, June 25th, 2022 16:35-17:05 Room 2(1F naruo)

Current knowledge about gastric non-H. pylori organisms(microbiota) in Japan and Korea

  • Chair: Yong Chan Lee
  • (Yonsei University, Korea)
  • Yoshio Yamaoka
  • (Oita University, Japan)
  • JS3-1 Current knowledge about gastric non-H. pylori organisms (microbiota) in Korea
  • Chan Hyuk Park
  • (Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea)
  • JS3-2 Genomic and virulence characteristics of non-Helicobacter pylori Helicobacter infecting the human stomach
  • Emiko Rimbara
  • (Department of Bacteriology II, National Institute of Infectious Diseases, Japan)

Young investigator Award(YIA) Presentation

Saturday, June 25th, 2022 17:05-18:25 Room 2(1F naruo)

  • Chair: Hwoon-Yong Jung
  • (Asan Medical Center, University of Ulsan College of Medicine, Korea)
  • Hitoshi Tsugawa
  • (Transkingdom Signaling Research Unit, Division of Host Defense Mechanism, Tokai University School of Medicine, Japan)
  • YIA-K1 Efficacy of Culture-Based Tailored Therapy as Primary Treatment of Helicobacter pylori Infection
  • Jeong Hoon Lee
  • (Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea)
  • YIA-K2 Regression of follicular gastritis after successful eradication of Helicobacter pylori
  • Yoo Min Han
  • (Department of Internal Medicine and Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, 06236, South Korea / Department of Internal Medicine, Seoul National University College of Medicine, Seoul, 03080, South Korea)
  • YIA-K3 Efficacy of a 10-day tegoprazan-based, non-bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication, open label, single arm study
  • Yong Hwan Kwon
  • (School of Medicine, Kyungpook National University, Daegu, South Korea / Department of Internal medicine, Kyungpook National University Hospital, Daegu, South Korea)
  • YIA-K4 Incidence of gastric cancer among H. pylori eradicated long-term proton pump inhibitor users in Korea
  • Jong Wook Kim
  • (Department of Gastroenterology, Inje University Ilsan Paik Hospital, Korea)
  • YIA-K5 Comparison of first-line bismuth containing 7-day quintet therapy and standard 14-day triple therapy for Helicobacter pylori Eradication
  • Young Hoon Chang
  • (Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea)
  • YIA-J1 DLST positivity rate for H. pylori eradication drugs
  • Tomohiro Higuchi
  • (First Department of Medicine, Hamamatsu University School of Medicine, Japan)
  • YIA-J2 Role of the stimulation of Porphyromonas gingivals-derived lipopolysaccharide in development of inflammatory gastric carcinogenesis.
  • Masayoshi Oriuchi
  • (Division of Gastroenterology, Tohoku University, Graduate School of Medicine, Japan)
  • YIA-J3 Intervention study of susceptibility testing based vonoprazan, amoxicillin, clarithromycin, and metronidazole 14 days concomitant therapy as fourth line Helicobacter pylori eradication
  • Soichiro Sue
  • (Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
  • YIA-J4 The Impact of Mobile Genetic Elements and Toxin-antitoxin system on Helicobacter pylori Adaptability and Antimicrobial Resistance: A Wisdom from Japan-South Korea Whole-Genome Sequence Collection
  • Ricky Indra Alfaray
  • (Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Oita 879-5593 Japan / Institute of Tropical Disease, Universitas Airlangga, Surabaya, 60115, Indonesia)
  • YIA-J5 Identification of the Helicobacter pylori Genomic Islands in a High Gastric Cancer Region
  • Batsaikhan Saruuljavkhlan
  • (Department of Environmental and Preventive Medicine, Oita University of Medicine, Yufu, Japan)

Closing Remarks

Saturday, June 25th, 2022 18:25-18:30 Room 2(1F naruo)

  • President of Korea College of Helicobacter and Upper Gastrointestinal Research:
  • Jong-Jae Park
  • (Korea University, Korea)

Oral Session

Saturday, June 25th, 2022 13:00-14:30 Room 3(2F atago)

  • Chair: Jae Gyu Kim
  • (Chung-Ang University College of Medicine, Korea)
  • Masumi Okuda
  • (Department of Pediatrics, Hyogo Medical University, Japan)
  • O-K1 Role of High Expression of Claudin-4 for Prediction of Synchronous Tumors in Patients with Early Gastric Cancer
  • Moon Kyung Joo
  • (Division of Gastroenterology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Korea)
  • O-K2 Establishment of patient-derived gastric cancer organoid model from tissue obtained by endoscopic biopsies
  • Jae Gyu Kim
  • (Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul 06973, Korea)
  • O-K3 Inverse association between Helicobacter pylori infection and eosinophilic esophagitis: A single tertiary center experience
  • Young Hoon Chang
  • (Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea)
  • O-K4 Development of New Liquid Type Rapid Urease Test Kit (Helico Test): Comparison with Other Kits
  • Hannah Lee
  • (Division of Gastroenterology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea)
  • O-K5 Proton pump inhibitors use and the risk of rheumatoid arthritis; A Nationwide Cohort Study
  • Tae Jun Kim
  • (Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea)
  • O-K6 The prediction of Helicobacter pylori infection by endoscopic erythematous/exudative gastritis
  • One Zoong Kim
  • (Uijeongbu Eulji Medical Center, Eulji University, Korea)
  • O-K7 Efficacy of tegoprazan-based Helicobacter pylori eradication therapy in Korea Dong Chan Joo
  • (Department of Internal Medicine, Pusan National University College of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179, Gudeok‑ro, Seo‑Gu, Busan 49241, Republic of Korea)
  • O-K8 Tailored Therapy with Bismuth add-on vs. Concomitant Therapy for H. pylori eradication
  • Soo Yeon Choi
  • (Department of Internal Medicine, St. Vincent Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea)
  • O-K9 Interval Advanced Gastric Cancer After Negative Endoscopy
  • Tae Jun Kim
  • (Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea)
  • O-J1 Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates
  • Kartika Afrida Fauzia
  • (Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan. / Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.)
  • O-J2 A reference panel of Helicobacter pylori strains for antimicrobial susceptibility test
  • Shunji Hayashi
  • (Kitasato University School of Medicine, Japan)
  • O-J3 Long-term cryopreservation of Helicobacter pylori strains
  • Shunji Hayashi
  • (Kitasato University School of Medicine, Japan)
  • O-J4 Genomic differentiation through host/microbiome adaptation within East Asian Helicobacter pylori
  • Ichizo Kobayashi
  • (Research Center for Micro-Nano Technology, Hosei University, Japan)